Melphalan
Phase II study of oral Melphalan in two cohorts of BRCA-related or BRCA wt platinum-resistant epithelial ovarian carcinoma (EOC)
Centro Coordinatore: I.R.S.T. IRCCS, Meldola
Principal Investigator: Ugo Federico Francesco De Giorgi
Sub Investigator: Vincenza Conteduca
Study Coordinator: Giorgia Ravaglia
In fase di apertura
Tipologia Studio
Prospettico
Patologie
Ovaio